Assessment of the role of activin A and transforming growth factor β in the regulation of AML12 cell growth

Hepatology

Volumn 25, Issue 6, 1997, Pages 1370-1375

  Zhang, You Qing ^a   Mashima, Hirosato ^a   Kanzaki, Makoto ^a   Shibata, Hiroshi ^a   Kojima, Itaru ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; CELL DNA; EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DNA TRANSFECTION; GENE EXPRESSION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ACTIVIN RECEPTORS; ACTIVINS; ANIMALS; CELL DIVISION; CELL LINE; DNA; DNA, COMPLEMENTARY; INHIBINS; LIVER; MICE; RECEPTORS, GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030906357     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250612     Document Type: Article

References (29)

1. Massague, J. The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
2. Vale W, Hsueh A, Rivier C, Yu J. The inhibin/activin family of hormones and growth factors. In: Sporn MA, Roberts AB, eds. Peptide Growth Factors and Their Receptors: Handbook of Experimental Pharmacology, vol 95. Berlin: Springer-Verlag, 1990:211-248.
3. Massague J. Receptors for the TGF-β family. Cell 1992;69:1067-1070.
4. Massague J, Attisano L, Wrana JL. The TGF-β family and its composite receptors. Trends Cell Biol 1994;4:172-178.
5. Laiho M, Weis FMB, Massague J. Concomitant loss of transforming growth factor receptor types I and II in TGF-β resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem 1990;265:18518-18524.
6. Laiho M, Weis FMB, Boyd F, Ignotz RA, Massague J. Responsiveness to transforming growth factor-β restored by genetic complementation between cells defective in TGF-β receptors I and II. J Biol Chem 1991;266:9108-9112.
7. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody M, Laiho M, Wang X-F, et al. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 1992;71:1003-1014.
8. Mathews LS, Vale W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 1991;65:973-982.
9. Attisano L, Carcamo J, Ventura F, Weis FMB, Massague J, Wrana JL. Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 1993;75:671-680.
10. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, Asano S, et al. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 1993;92:1491-1496.
11. Bissell DM, Wang S-S, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-β in rat liver: evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995;96:447-455.
12. Kogure K, Omata W, Kanzaki M, Zhang YQ, Yasuda H, Mine T, Kojima I. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology 1995;- 108:1136-1142.
13. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. Activin-binding protein from rat ovary is follistatin. Science 1990;247:836-838.
14. Hashimoto M, Nakamura T, Inoue S, Kondo T, Yamada R, Eto Y, Sugino H, et al. Follistatin is a developmentary regulated cytokine in neural differentiation. J Biol Chem 1992;267:7203-7206.
15. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
16. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with micro satelite instability. Science 1995;268:1336-1338.
17. Lu SL, Akiyama Y, Nagasaki H, Saito K, Yuasa Y. Mutations of the TGF-β type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem Biophys Res Commun 1995;216:452-457.
18. Mashima H, Kanzaki M, Nobusawa R, Zhang Y-Q, Suzuki M, Mine T, Kojima I. Derangements in the activin-follistatin system in hepatoma cells. Gastroenterology 1995;108:834-840.
19. Wu JC, Merlino G, Fausto N. Establishment and characterization of differentiated, nontransfomed hepatocyte cell lines derived from mice transgenic of transforming growth factor α. Proc Natl Acad Sci USA 1994;91:674-678.
20. Hemmati-Brivanlou A, Melton DA. A truncated activin receptor dominantly inhibits mesoderm induction and formation of axial structures in Xenopus embryos. Nature 1992;359:609-614.
21. Chen R-H, Ebner R, Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 1993;260:1335-1338.
22. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936-942.
23. Zhang YQ, Kanzaki M, Mashima H, Mine T, Kojima I. Norepinephrine reverses the effects of activin A on DNA synthesis and apoptosis in cultured rat hepatocytes. HEPATOLOGY 1996;23:288-293.
24. Kelly D, Campbell WJ, Tiesman J, Rizzino A. Regulation and expression of transforming growth factor type β during early mammalian development. Cytotechnology 1990;4:227-242.
25. Zhang YQ, Kanzaki M, Mine T, Kojima I. Characterization of the activin receptor in cultured hepatocytes. HEPATOLOGY 1996:24:446-450.
26. Eto Y, Tsuji T, Kakegawa M, Takano S, Yokogawa T, Shibai H. Purification and characterization of erythroid differentiation factor isolated from human leukemia cell line, THP-1. Biochem Biophys Res Commun 1987;42:1095-1100.
27. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. Activin-binding protein from rat ovary is follistatin. Science 1990;247:836-838.
28. Hill P, Reynolds JJ, Meikle MC. The purification and partial characterization of bone resorptive polypeptides from bovine bone matrix. Biochim Biophys Acta 1994;1201:193-202.
29. 1 phase. J Cell Biochem 1992;50:255-265.